Extracellular ATP (eATP) is an ancient 'danger signal' used by eukaryotes to detect cellular damage 1 . In mice and humans, the release of eATP during inflammation or injury stimulates both innate immune activation and chronic pain through the purinergic receptor P2RX7 2-4 . It is unclear, however, whether this pathway influences the generation of immunological memory, a hallmark of the adaptive immune system that constitutes the basis of vaccines and protective immunity against re-infection 5,6 . Here we show that P2RX7 is required for the establishment, maintenance and functionality of long-lived central and tissue-resident memory CD8 + T cell populations in mice. By contrast, P2RX7 is not required for the generation of short-lived effector CD8 + T cells.
T RM population, in various non-lymphoid sites (Fig. 1d , Extended Data Fig. 1a-c ). P2RX7 deficiency compromised T CM and T RM cell generation by polyclonal P2rx7 −/− CD8 + T cells and in response to other acute viral infections (Extended Data Fig. 1f, g ), suggesting that these results are generalizable. Furthermore, P2rx7 −/− P14 cells showed an impaired response to chronic LCMV infection, especially generation of CXCR5 + cells (a subset of 'exhausted' CD8 + T cells that retain functionality) [11] [12] [13] ( Fig. 1e , f, Extended Data Fig. 1h ). Cell-surface expression of P2RX7 increases following CD8 + T cell activation and is highest on T CM and CD69 high /CD103 high T RM cells (Extended Data Fig. 2a-f ), corresponding with the effect of P2RX7 deficiency on these subsets. Similarly, reactivity to BzATP (an eATP analogue) correlated with P2RX7 expression on memory CD8 + T cell subsets, indicating that P2RX7 mediates the sensitivity of memory CD8 T cells to normal eATP (Extended Data Fig. 2g, h) . Hence, the eATP sensor P2RX7 is essential for establishment of the most durable memory CD8 + T cell populations in lymphoid and many non-lymphoid tissues.
We next investigated the role of P2RX7 in early differentiation of memory CD8 + T cells. Although P2rx7 −/− P14 cells initially formed both short-lived effector cells (SLECs) and memory precursor effector cells (MPECs), this was followed by a selective decline in MPECs ( Fig. 2a ) whereas SLEC maintenance was largely unaffected ( Fig. 2a , Extended Data Fig. 3a ). RNA sequencing (RNA-seq) analysis revealed minimal changes in gene expression by P2rx7 −/− MPECs (Extended Data Fig. 3b ), prompting us to evaluate other potential mechanisms of MPEC decline. Cellular metabolism is reprogrammed during the transition from activated to memory CD8 + T cells 14 , resulting in enhanced oxidative phosphorylation (OXPHOS), fatty acid oxidation and mitochondrial maintenance 15, 16 . Previous studies have suggested that P2RX7 regulates metabolic processes, although there is evidence for both beneficial and detrimental effects on cell viability 7, 17 . As early as eight days post-infection, P2rx7 −/− MPECs exhibited lower mitochondrial mass, mitochondrial membrane potential and glucose uptake, while SLECs were minimally affected ( Fig. 2b, c , Extended Data Fig. 3c-g) . Furthermore, in extracellular flux assays P2rx7 −/− MPECs (but not SLECs) exhibited a lower oxygen consumption rate (OCR) and reduced spare respiratory capacity-an indicator of the metabolic resilience of cells under stress, and a trait of CD8 + T CM cells 15 (Fig. 2d, e ). These findings are consistent with proposals that calcium influx through P2RXs promotes mitochondrial activity in short-term activated T cells 17, 18 . Aerobic glycolysis (measured by extracellular acidification rate (ECAR)) was only slightly reduced in P2rx7 −/− MPECs (Extended Data Fig. 3h ), such that the OXPHOS/aerobic glycolysis ratio (OCR/ ECAR) of P2rx7 −/− MPECs resembled that of SLECs (Fig. 2f ). The impact of P2RX7 deficiency persisted into the memory phase, P2rx7 −/− P14 cells displaying defective glucose uptake, mitochondrial maintenance and function, and fatty acid uptake. Most of these defects affected T CM cells more substantially than T EM cells ( Fig. 2g -i, Extended Data Fig. 3i-m) . Thus, our findings suggest that the eATP receptor P2RX7 is Letter reSeArCH critical for mitochondrial homeostasis and normal metabolic function in differentiating memory CD8 + T cells.
Metabolic defects might be predicted to compromise T cell survival. Indeed, basal proliferation of P2RX7-deficient memory P14 cells was normal, but they exhibited increased cell death (Extended Data Fig. 4a-c) . Correspondingly, P2rx7 −/− MPECs and T CM cells exhibited slightly reduced protein expression of the anti-apoptotic factor BCL2 and the transcription factors TCF1 and EOMES (associated with T CM differentiation 19 ), whereas SLEC and T EM cell populations were much less affected (Extended Data Fig. 4d-f ). Similar outcomes resulted when wild-type and P2rx7 −/− P14 cells were adoptively transferred separately (data not shown). Survival of T CM cells is supported by interleukin (IL)-7 and IL-15 5 , but although P2rx7 −/− P14 cells displayed reduced cell surface expression of the IL-7 receptor IL-7Rα, they showed normal dependence on IL-15 for homeostasis (Extended Data Fig. 4g-i ). Furthermore, P2rx7 −/− P14 cells outcompeted wild-type cells for lymphopenia-induced proliferation (Extended Data Fig. 4j , k)a homeostatic response to IL-7 and IL-15 that does not involve strong TCR stimulation 20 . Together, these data suggest that impaired cytokine sensitivity is not the basis of defective P2rx7 −/− CD8 + T CM cell maintenance.
To explore how P2RX7 selectively controls the metabolism of differentiating CD8 + memory T cells, we used in vitro assays in which activated CD8 + T cells cultured with IL-2 or IL-15 acquire effector-or memory-like properties, respectively 15, 21 . Wild-type and P2rx7 −/− P14 cells responded similarly to IL-2, but in IL-15 cultures P2rx7 −/− cells progressively declined in viability ( Fig. 3a ), analogous to defective memory survival in vivo (Extended Data Fig. 4c ). Furthermore, after 72 h of IL-15 culture, P2rx7 −/− P14 cells developed profound decreases in maximum OCR levels and spare respiratory capacity (SRC) (Fig. 3b , c) within the viable population (Extended Data Fig. 5a ). IL-15-polarized P2rx7 −/− P14 cells also displayed defective aerobic glycolysis (Extended Data Fig. 5b ) and decreased mitochondrial mass and membrane potential (Extended Data Fig. 5c, d ). These results are unlikely to reflect altered cytokine sensitivity, as P2rx7 −/− and wild-type P14 cells showed similar pSTAT5 induction and re-expression of CD62L in IL-15 cultures 21 (Extended Data Fig. 5e , f) and normal expansion (Extended Data Fig. 5g ). IL-2-polarized P2rx7 −/− P14 cells showed some dysfunction (reduced mitochondrial mass and impaired aerobic glycolysis), suggesting that P2RX7 also alters effector metabolism, although P2rx7 −/− effector cell generation was normal in vivo ( Fig. 2a ). Hence, the ability of P2RX7 to control metabolism in nascent memory CD8 + T cells could be modelled in vitro.
Metabolic programming in T cells entails mitochondrial remodelling, and the development of fused mitochondria in memory CD8 + T cells correlates with more efficient OXPHOS 22 . Analysis of mitochondrial ultrastructure showed that IL-15-polarized P2rx7 −/− P14 cells fail to form the fused mitochondrial networks seen in wild-type cells, more closely resembling IL-2-cultured effector cells ( Fig. 3d , Extended Data Fig. 6a ). Furthermore, in vitro-and in vivo-activated P2rx7 −/− P14 cells exhibited increased proton leak during respiration at multiple stages of differentiation (Extended Data Fig. 6b-d ), suggesting mitochondrial damage 22 . These data indicate that P2RX7 deficiency impairs the dynamic mitochondrial reorganization associated with memory CD8 + T cell differentiation. OPA1 drives mitochondrial fusion in T cells 22 , and OPA1 expression was reduced in IL-15-polarized P2rx7 −/− Letter reSeArCH P14 cells (Extended Data Fig. 6e , f). However, OPA1 levels were proportional to total mitochondrial protein (Extended Data Fig. 6g , h) and it is unclear whether reduced OPA1 expression is a cause or consequence of dysregulated mitochondrial homeostasis in P2rx7 −/− CD8 + T cells.
It is possible that P2RX7 deficiency affected T cells before activation and differentiation. However, metabolism of naive P2rx7 −/− CD8 + T cells was normal (Extended Data Fig. 7a-c ). Furthermore, treatment with A-438079 (a highly specific P2RX7 inhibitor 23 ) during CD8 + T cell activation and IL-15 polarization resulted in dysregulated metabolism similar to that of P2rx7 −/− CD8 + T cells (Fig. 3e ). These findings also provided an opportunity to extend our observations to human T cells. Treatment with A-438079 caused substantial loss of OXPHOS and aerobic glycolysis in activated human T cells ( Fig. 3f , Extended Data Fig. 7d ), and a substantial decrease in their proliferation and cytokine production ( Fig. 3g, h ), but short-term survival was not altered (Extended Data Fig. 7e ). Hence, while having some speciesspecific effects, blockade of P2RX7 compromises the metabolism of both human and mouse activated CD8 + T cells.
Our data suggested that eATP would promote CD8 + T cell metabolism and growth. Indeed, eATP blockade (using the ATP diphosphatase apyrase or the competitive inhibitor oATP) impaired expansion and OCR of IL-15-cultured P14 CD8 + T cells, while low concentrations of BzATP had the opposite effect ( Fig. 3i , Extended Data Fig. 8a-e ). Such doses of BzATP induced calcium mobilization but minimal pore formation (Extended Data Fig. 8f ), consistent with studies suggesting that P2RX7-induced calcium flux enhances mitochondrial function 7,10,17 . None of these compounds are P2RX7 specific, yet their effects on 
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CD8 + T cells were entirely P2RX7-dependent ( Fig. 3i , Extended Data Fig. 8a-f ). Furthermore, short-term P2RX7 inhibition blocked OCR in IL-15-cultured CD8 + T cells (Extended Data Fig. 8g ). Hence, these studies suggest that physiological levels of eATP promote mitochondrial metabolism and growth of activated CD8 + T cells via a pathway that requires P2RX7. An important issue was the source of eATP triggering P2RX7 signalling. While eATP is released from tissues during infection and injury 1, 7 , eATP is also exported by healthy activated T cells through Pannexin 1 (PANX1) channels, which may themselves be triggered by P2RX7 signalling 18, 24 . In this way, activated T cells could autonomously maintain P2RX7 signalling by both exporting and responding to eATP, perpetuating mitochondrial function through sustained calcium ion influx (and/or other functions of P2RX7). Both extrinsic and PANX1-derived eATP have been proposed to influence effector CD4 + T cell differentiation 10 . Notably, inclusion of the PANX1 inhibitor probenecid during in vitro generation of CD8 + T cell memory-like cells caused impaired OXPHOS and reduced SRC, similar to P2rx7 −/− CD8 + T cells ( Fig. 3j, k ), suggesting that PANX1 can regulate the same metabolic pathways. Consistent with a role for P2RX7 and PANX1 in ATP export, intracellular ATP concentrations were elevated and extracellular ATP concentrations were decreased in P2rx7 −/− effector CD8 + T cells, and PANX1 was critical for eATP (Extended Data Fig. 8h , i).
Elevated intracellular ATP concentrations could lead to impaired activation of AMP-activated protein kinase (AMPK), which controls adaptation to environmental stress 25 , restrains mTOR activity and promotes the transition from effector to memory CD8 + T cells 14, 26 . Indeed, mTOR activity (indicated by pS6 levels) was elevated in memory P2rx7 −/− T cells (Extended Data Fig. 8j ). More directly, IL-15polarized P2rx7 −/− CD8 + T cells exhibited decreased phosphorylation of the AMPK target acetyl-CoA carboxylase (pACC; Fig. 3l ). AMPK is also activated by intracellular calcium 14 , and stimulation with BzATP at doses that promote efficient calcium flux (Extended Data Fig. 8f ) increased the pACC/pS6 ratio in wild-type but not P2rx7 −/− CD8 + T cells (Extended Data Fig. 8k ). Furthermore, in vitro treatment with AICAR (a pharmacological AMPK activator) largely corrected defective OCR and survival in P2rx7 −/− CD8 + T cells ( Fig. 3m , Extended Data Fig. 8l ). In vivo, activation of AMPK using metformin enhanced generation of P2rx7 −/− CD8 + T CM and T RM cells (while minimally affecting circulating T EM cells), and partially or completely restored normal mitochondrial mass and membrane potential in P2rx7 −/− P14 T CM cells ( Fig. 3n , Extended Data Fig. 8m-o) . Similarly, transient blockade of mTOR with rapamycin improved production of P2rx7 −/− T CM cells ( Fig. 3o , Extended Data Fig. 8p ). Collectively, these data indicate that P2RX7 activates AMPK, which, perhaps via mTOR inhibition, supports the generation of long-lived memory CD8 + T cells.
In vitro cytotoxicity and granzyme B expression was normal in P2rx7 −/− P14 effector cells (data not shown), but the functionality of P2rx7 −/− memory CD8 + T cells has been unclear. Equivalent numbers of wild-type or P2rx7 −/− memory P14 cells were independently evaluated for response to vaccinia virus expressing gp33 (Fig. 4a ), and P2rx7 −/− P14 cells showed reduced recall expansion ( Fig. 4b ) and viral control ( Fig. 4c ). Impaired control of LCMV clone 13 was also observed in polyclonal P2rx7 −/− mice (Extended Data Fig. 9a ). P2rx7 −/− P14 cell recall responses to recombinant Listeria were also blunted, correlating with increased cell death rather than impaired proliferation (Extended Data Fig. 9b-f ). Likewise, following local antigen challenge of female reproductive tract T RM cells (using transcervical peptide stimulation 27 ), fewer P2rx7 −/− P14 T RM cells produced IFN-γ or granzyme B, accompanied by reduced activation of 'bystander' CD8 + T cells and maturation of local dendritic cells ( Fig. 4d , Extended Data Fig. 9g, h) . These data demonstrate that P2RX7 is critical not only for maintenance of memory CD8 + T cells but also for their function.
P2RX7 is considered a promising pharmacological target for chronic pain treatment 7,28 . Thus, we investigated whether P2RX7 blockade therapies designed to treat neuropathic pain would impede generation of CD8 + T cell memory, developing a combined model of spared nerve Letter reSeArCH injury with LCMV infection (Extended Data Fig. 9i-k) . Transient in vivo treatment with A-438079 significantly attenuated nerve injuryinduced hypersensitivity (Fig. 4e ) and, in parallel, significantly decreased production of memory CD8 + T cells, especially T CM cells, one month later (Fig. 4f ). Furthermore, A-438079 treatment during the week following LCMV infection reduced subsequent generation of memory and MPEC (but not SLEC) P14 cells, resembling the defects of P2rx7 −/− CD8 + T cells (Extended Data Fig. 9l-n) . A-438079 also impaired CD8 + T CM and T RM cell generation in LCMV infected BALB/c mice, which express a functionally distinct P2rx7 allele 7 (Extended Data Fig. 9o ). Notably, P2RX7 blockade caused loss of pre-existing memory CD8 + T cells, especially T CM cells, suggesting that P2RX7 is required for maintenance of CD8 + T cell memory (Fig. 4g, Extended Data Fig. 9p ). Hence, therapeutic P2RX7 inhibition may inadvertently compromise the development or maintenance of long-lived CD8 + T cell memory.
A paradigm shift in immunology came with understanding that detection of pathogen-and danger-associated molecular patterns are critical to spark immune reactivity 29, 30 . eATP is one of these triggers, representing a primordial mechanism for indicating tissue injury and inflammation 1 , but the effect of this pathway on adaptive immune memory has been unclear. We show here that the eATP sensor P2RX7 has a hitherto unsuspected intrinsic role in supporting the generation of long-lived memory CD8 + T cells by driving their metabolic reprogramming and mitochondrial maintenance. Thus, eATP, produced by damaged tissue or exported by activated cells, not only triggers innate immune activation and inflammatory nociception but also promotes durable adaptive immunological memory (Extended Data Fig. 10 ).
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MEthodS
Mice and infections. Six-to-eight-week old C57BL/6 (B6) and B6.SJL (expressing the CD45.1 allele) mice were purchased from Charles River (via the National Cancer Institute). P2rx7 −/− , Rag2 −/− and CX3CR1 gfp/gfp mice were obtained from Jackson Laboratories. LCMV-D b GP33-specific TCR transgenic P14 mice were fully backcrossed to B6 and P2rx7 −/− mice, with introduction of CD45.1 and CD45.2 congenic markers for identification. Female mice were infected with LCMV Armstrong strain (2 × 10 5 PFU, intraperitoneally (i.p.)), LCMV clone 13 strain (2 × 10 6 PFU, intravenously (i.v.)) or VSV-OVA (1 × 10 6 PFU, i.v.). In some experiments, the LCMV viral titres in the kidneys of clone 13-infected mice were evaluated by standard plaque assay. In challenge experiments, mice were first infected with LCMV and, 6-8 weeks later, inoculated with Listeria monocytogenes (Lm)-GP33 (8 × 10 4 CFU). For vaccinia challenge experiments, wild-type and P2rx7 −/− memory P14 cells were sort-purified from CD45.1 congenic mice that had received wild-type or P2rx7 −/− P14 cells, respectively, and were infected with LCMV four weeks before being killed. Wild-type or P2rx7 −/− memory P14 cells (2 × 10 4 ) were separately transferred into naive CD45.1 congenic recipient mice, which were then infected with VacV-gp33. After 7 days, mice were killed, spleens were removed for analysis of cell expansion, and ovaries were isolated for viral titre assessment by plaque assay. Viral titration was performed following a previously described protocol 31 . In brief, ovaries were homogenized in RPMI + 1% FBS containing penicillin and streptomycin with the aid of a handheld homogenizer, and serial dilutions of homogenates were plated on 143B cells (ATCC CRL-8304, mycoplasma status untested) for viral growth. After two days, plaques were enumerated after crystal violet staining. Transcervical challenges with GP33 peptide (50 μg per mouse) were performed as described 32 . Animals were maintained under specific-pathogen-free conditions at the University of Minnesota. All experimental procedures were approved by the institutional animal care and use committee at the University of Minnesota. No statistical methods were used to predetermine sample size. Animals were randomly allocated for infection and treatment groups. Investigators were not blinded unless otherwise indicated (see Spared nerve injury (SNI) model and measurement of mechanical sensitivity). Administration of A-438079 to mice. A-438079 (Sigma-Aldrich) (in 0.5% DMSO in PBS) was administered to mice i.p. daily during the indicated treatment periods at a daily dose of 80 mg kg −1 (which has been shown to inhibit nociceptive pain in murine models 33 ). Three different regimens of administration were used, in which A-438079 was given between days 1 and 7, between days 4 and 6 or between days 40 and 50 relative to LCMV infection. Control mice received daily vehicle injections (0.5% DMSO in PBS) during the same time periods. Administration of metformin and rapamycin in mice. Metformin (Sigma-Aldrich) was administered to mice i.p. daily between days 1 and 7 after LCMV infection. The daily dose of metformin was 200 mg kg −1 , which has been shown to potentiate memory CD8 + T cell generation 26 . Control mice received daily vehicle injections (0.1% DMSO in PBS) during the same period. Rapamycin (LC Laboratories) was administered to mice i.p. daily between days 4 and 8 after LCMV infection. The dose of rapamycin was 75 μg kg −1 per day, as previously used during acute viral infection 34 . Control mice received daily vehicle injections (0.01% DMSO in PBS) during the same period. Flow cytometry. Lymphocytes were isolated from tissues including spleen, inguinal lymph nodes, cervical lymph nodes, blood, lung, gut intestinal epithelium, gut intestinal lamina propria, female reproductive tract, kidney and salivary glands as previously described 35, 36 . During isolation of lymphocytes from nonlymphoid tissues, 50 μg Treg-Protector (anti-ARTC2.2) nanobodies (BioLegend) were injected i.v. 15-30 min before mice were killed. Direct ex vivo staining and intracellular cytokine staining were performed as previously described 36, 37 with fluorochrome-conjugated antibodies (purchased from BD Biosciences, BioLegend, eBioscience, Cell Signaling Technology, Tonbo or Thermo Fisher Scientific). CXCR5 staining was performed as previously described 12 . To detect LCMV-specific CD8 + T cell responses, tetramers were prepared as described 38 . For discrimination of vascular-associated lymphocytes in non-lymphoid organs, in vivo i.v. injection of PE-conjugated CD8α antibody was performed as described 39 . Among LCMV-specific CD8 + T cells, the following markers were used to distinguish these respective populations: T CM (CD44 + CD62L + ), T EM (CD44 + CD62L − CD127 + ), T RM (i.v.CD8α − CD69 +/− CD103 high/int/low ), LLECs (CD44 + CD62L − KLRG1 + CX3CR1 high ), MPECs (CD127 + KLRG1 − ), and SLECs (CD127 − KLRG1 + ). For detection of in vivo proliferation, cells were stained with Ki-67 using the Foxp3 kit for fixation and permeabilization. Alternatively, proliferation was assessed by BrdU incorporation as described 40 . For survival assessment, cells were stained with Live/Dead (Tonbo Biosciences) and, when mentioned, with annexin V-FITC (eBiosciences). For assessment of homeostatic proliferation, wildtype or P2rx7 −/− P14 cells were stained with CFSE and transferred into Rag2 −/− mice (2 × 10 6 cells per mouse) as described 41 . The numbers and percentages of CFSE low cells were assessed within the next 3 weeks. After this period, mice were killed and the proliferation of spleen P14 cells was assessed. For measurement of mitochondrial mass and membrane potential, cells were incubated with MTG (Thermo Fisher Scientific) and TMRE (Cell Signaling Technology) simultaneously for 15 min at 37 °C before ex vivo staining. For assessment of glucose uptake, cells were incubated with 50 μg ml −1 2-NBDG (Cayman Chemicals) for 2 h at 37 °C before ex vivo staining. For measurement of intracellular fatty acid levels, cells were incubated with 1 μg ml −1 Bodipy 493/503 (Thermo Fisher Scientific) for 20 min at 37 °C before ex vivo staining. For assessment of proliferation upon in vitro stimulation, CD8 + T cells were labelled with Cell Tracer Violet (CTV; Life Technologies) and after stimulation were stained ex vivo. For detection of intracellular factors such as BCL2, EOMES and TCF1, surface-stained cells were permeabilized, fixed and stained using the eBioscience Foxp3 staining kit, according to the manufacturer's instructions. For intracellular detection of pS6, ex vivo stained cells were fixed, permeabilized using the Phosflow Perm Buffer III (BD Biosciences) and stained with pS6 for 1 h at room temperature. For intracellular detection of pACC, cultured cells were fixed with paraformaldehyde 1%, permeabilized with 90% methanol and stained with pACC for 20 min at room temperature. Surface staining was performed after fixation to minimize effects on AMPK signalling. For assessment of calcium influx, cells were stained with surface markers, then incubated for 1 h at 37 °C with 1 μM Indo-1 (Thermo Fisher Scientific) and then washed, while for detection of large molecular weight pore formation, DAPI (Thermo Fisher Scientific; 1 μM) was added to the cell culture just before assay. In both cases, cells were analysed by kinetic flow cytometry, a baseline reading being determined for 1 min then BzATP (Sigma-Aldrich; 100 or 300 μM) added and the analysis continued for the remaining ~30 min. The ratios between bound Indo-1 and free Indo-1 were used as a measurement of calcium influx and uptake of DAPI was measured in the BV-421 channel. Flow cytometric analysis was performed on a LSR II or LSR Fortessa (BD Biosciences) and data were analysed using FlowJo software (Treestar). Cell sorting. Cell sorting was performed on a FACS Aria III device (BD Biosciences). RNA-seq and extracellular flux analysis experiments were performed on KLRG1 + CD127 − (SLEC) and KLRG1 − CD127 + (MPEC) CD8 + T cells sorted from mice 8 or 14 days post-LCMV infection, respectively. The population purity after cell sorting was >95% in all experiments. RNA-seq analysis. MPECs and SLECs were first homogenized eight days after LCMV infection using QIAshredder columns (Qiagen) and RNA was then extracted using an RNeasy kit (Qiagen) following the manufacturer's instructions. After quality control, total RNA samples were processed with the Illumina TotalPrep-96 RNA Amplification Kit for HighThroughput RNA Amplification for Array Analysis, and read in a HiSeq 2500 System (high output sequencing, paired end read, 125 bp). Metabolic assays. OCR and ECAR were assessed using a 96-well XF Extracellular flux analyser, according to the manufacturer's instructions (Seahorse Bioscience). SRC, OCR/ECAR ratios and proton leak were defined as previously described 15, 22 . In some extracellular flux assays, BzATP (300 μM), oATP (EMD Millipore; 50 μM) or apyrase (New England Biolabs; 10 U ml −1 ) were added either at the port or 1 h before analysis. In other experiments, A-438079 (25 μM) was added 6 h prior to analysis. Intracellular ATP concentrations were measured by using the ATP determination kit (Life Technologies). To assess the levels of extracellular ATP, wild-type or P2rx7 −/− P14 cells were activated in vitro and polarized with IL-2 or IL-15 as described above, except that the cytokine polarization cultures were performed in Transwells (Corning). After 24 h of polarization, the transwells were transferred to new wells and the plates were centrifuged at 50 r.p.m. for 1 min. The supernatant below the transwells was quantified for ATP concentration as described above. In all transwells, a combination of the plasma membrane ATPase inhibitor ebselen (30 μM; Cayman Chemical) and the ecto-ATPase inhibitor ARL 67156 trisodium salt hydrate (100 μM; Sigma-Aldrich) was added 1 h before evaluation, to inhibit ATPase activity 42 . In some samples, a Pannexin 1 inhibitor ( 10 Panx, Tocris) was added 20 h before assessment. Transmission electron microscopy. Cells were fixed in 2.5% glutaraldehyde in 100 mM sodium cacodylate, followed by post-fixation in 1% osmium tetroxide. After extensive washing, samples were stained in 1% uranyl acetate for 30 min in the dark, then washed again. Samples were dehydrated in ethanol and embedded in eponate resin. Cells were imaged using a JEOL 1200 EXII transmission electron microscope equipped with a SIS MegaView III high resolution CCD camera (1,376 × 1,032-pixel format, 12 bit). Mitochondrial areas were calculated using ImageJ software (NIH). Protein quantification. Western blotting of total protein lysates was performed as previously described 22 . The following antibodies were used: Opa1 (BD Biosciences) and β-actin (Cell Signaling Technologies). Primary incubations were followed by incubation with secondary HRP-conjugated antibodies (Santa Cruz Biotechnology). Blots were revealed using the Biomax MR film (Kodak).
To quantify the total mitochondrial protein amounts, mitochondria were isolated from experimental P14 cells by using the Qproteome Mitochondria Isolation Kit (QIAgen), following the manufacturer's instructions. The mitochondria protein extracts were quantified using the Pierce BCA protein kit (Thermo Fisher).
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In vitro culture experiments. P14 splenocytes from naive mice were stimulated for 72 h with gp33 peptide (1 μM, KAVYNFATM, New England Peptide) and IL-2 (10 ng ml −1 ). When indicated, probenecid (100 μM, Sigma-Aldrich) or A-438079 (25 μM) was added to the cultures (48 h before analysis). Where indicated, P14 cells were isolated with the mouse CD8 + T cell isolation kit (Miltenyi Biotech) 72 h after initial activation, and incubated for an additional 72 h or 7 days with IL-2 or IL-15 to induce generation of effector-like and memory-like populations, as previously described 21 . Cell numbers were assessed by Neubauer chamber counting. Survival was analysed by Trypan blue staining during microscope counting, and confirmed by Live-Dead (Tonbo Biosciences) staining using flow cytometry. For all experiments, complete RPMI medium (RPMI 1640 supplemented with 10% FBS, 100 U ml −1 penicillin/streptomycin, 2 mM l-glutamine) was used. In some experiments, IL-2-or IL-15-cultured P14 cells were cultured in the presence of 100 μM-1 mM BzATP for 72 h and cell numbers and survival were measured as indicated. In other experiments, IL-2-or IL-15-cultured P14 cells were cultured in the presence of either 50-100 μM oATP or 10 U ml −1 apyrase for 72 h, and cell numbers and survival were measured as indicated. In some experiments, IL-2-or IL-15-cultured P14 cells were cultured in the presence of 500 μM AICAR (Sigma-Aldrich) for 72 h, and cell numbers and survival were measured as indicated. For extracellular flux analysis, AICAR was added 6 h before assay. Survival of wild-type and P2rx7 −/− cells in extracellular flux assay medium was assessed by the WST-1 viability assay according to the manufacturer's instructions (Sigma-Aldrich). Human CD8 + T cell studies. Resting CD8 + T cells were isolated from Ficollpurified PBMCs isolated from leukapheresis products (Memorial Blood Center, St. Paul, MN) in a two-step process by first depleting CD25 + cells using using (cGMP)-grade anti-CD25 microbeads (Miltenyi Biotec) on an AutoMACS (Miltenyi Biotec). CD8 + cells were then purified from the CD25 − fraction using negative selection (CD8 + T cell isolation kit, Miltenyi Biotec). Purified cells were stimulated for 72 h with αCD3/αCD28 beads (InVitrogen) and IL-2 (300 U ml −1 ). After 20 h, A-438079 (25 μM) or PBS was added to the cultures. Cell numbers were analysed by Neubauer chamber counting. Survival was analysed by Trypan blue staining during microscope counting and confirmed by Live-Dead (Tonbo Biosciences) staining using flow cytometry. Spared nerve injury (SNI) model and measurement of mechanical sensitivity. The SNI model produces substantial and prolonged changes in mechanical sensitivity and cold responsiveness that closely mimic the cutaneous hypersensitivity associated with clinical neuropathic pain 43 . SNI surgeries were performed under isoflurane anaesthesia as described 44 . Fourteen days after SNI the mice were infected with LCMV and treated with A-438079 (80 mg kg −1 ) or vehicle on days 1-7 post-infection. For assessment of mechanical sensitivity, mechanical withdrawal thresholds were tested using von Frey filaments. Mice were acclimated for at least 30 min in the testing environment within a plastic box on a raised metal mesh platform. A logarithmically increasing set of eight von Frey filaments (Stoelting), labelled from 0.07 to 6.0 g, were used. These were applied perpendicular to the ventral-lateral hindpaw surface with sufficient force to cause a slight bending of the filament. A rapid withdrawal of the paw away from the stimulus fibre within 4 s was deemed as a positive response. Using an up-down statistical method 45 , the 50% withdrawal threshold was calculated for each mouse and then averaged within the experimental groups. Mechanical withdrawal thresholds were measured at baseline, on day 14 post-SNI, and 6 h after the last drug treatment. As these measurements involved immediate investigator interpretation, investigator blinding to the group identities was used. Statistical analysis. Data were subjected to the Kolmogorov-Smirnov test to assess Gaussian distribution. Statistical differences were calculated by using unpaired two-tailed Student's t-test or one-way ANOVA with Tukey's post-test where indicated. All experiments were analysed using Prism 5 (GraphPad Software). P values of <0.05*, <0.01** or <0.001*** indicate significant differences between groups.
Exact P values for all experiments are provided in Supplementary Table 1 . Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper. Data availability. The data that support the findings of this study are available from the corresponding author upon reasonable request. 
Extended Data Fig. 4 | P2RX7 signalling is required for survival rather than homeostatic proliferation of long-lived memory CD8 + T cells. a-g, Wild-type (black) and P2rx7 −/− (red) P14 CD8 + T cells were mixed 1:1 and co-adoptively transferred into B6.SJL mice that were subsequently infected with LCMV, and donor cells were identified as in Fig. 1 (data from three independent experiments, n = 4-10 from all experiments). a-d, Percentages of Ki-67 + cells (ex vivo staining; a), BrdU + cells (b) and annexin V + Live-Dead + cells (c), and BCL2 median fold increase (relative to median values of naive CD8 + T cells) for bulk, T CM and T EM subsets (d) was determined for wild-type and P2rx7 −/− P14 CD8 + T cells eight weeks after infection. e, Median fold increase (relative to naive CD8 + T cells) in expression of TCF1 (left), BCL2 (centre) and EOMES (right) in wildtype and P2rx7 −/− P14 MPEC and SLEC CD8 + T cells at the indicated times. f, Expression of TCF1 (left) and EOMES (right) (shown as median expression relative to naive CD8 + T cells) in splenic T EM and T CM subsets of wild-type and P2rx7 −/− P14 CD8 + T cells, four weeks after infection. g, CD127 (left) and CD122 (right) median expression (relative to naive CD8 + T cells) for splenic bulk cells and T CM and T EM subsets four weeks after infection. h, i, Wild-type and P2rx7 −/− P14 CD8 + T cells were mixed 1:1 and co-adoptively transferred into B6.SJL or IL-15 −/− mice, which were subsequently infected with LCMV (data from two independent experiments, n = 4-5 from all experiments). h, Numbers of wild-type and P2rx7 −/− P14 CD8 + T cells in each host (four weeks after infection). i, Ratio of total and T CM P2rx7 −/− to wild-type P14 CD8 + T cells in spleens from wild-type and IL-15 −/− hosts at indicated times post-infection. j, k, Congenically distinct wild-type and P2rx7 −/− P14 CD8 + T cells were stained with CFSE, mixed 1:1 and co-adoptively transferred into Rag2 −/− mice. Data from two independent experiments, n = 6 total. j, Ratio of P2rx7 −/− to wild-type P14 CD8 + T cells in the blood of Rag2 −/− hosts at indicated times post-transfer. k, Percentages of P2rx7 −/− and wild-type P14 CD8 + T cells proliferating over four cycles in spleens of Rag2 −/− hosts three weeks after transfer. All data shown as mean ± s.e.m. a-d, f-h, k, Two-tailed Student's t-test; e, two-way ANOVA with Bonferroni's post-test; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. Fig. 3b ) (c) for OCR. Graphs show values for proton leak (the difference in OCR values after oligomycin and after antimycin A/rotenone addition; Fig. 3b ). Data are from three independent experiments (n = 11-18 total). d, Calculated proton leak derived from OCR measurements on in vivo activated wild-type and P2rx7 −/− P14 CD8 + MPECs described in Fig. 2d -f (data from three independent experiments, data pooled from five mice per experiment; n = 4-6 wells in total). e-h, Wild-type and P2rx7 −/− P14 cells were activated in vitro and polarized with either IL-2 or IL-15 (as in Fig. 3b ); total cell (e-g) and mitochondrial (g, h) protein extracts were collected for protein quantification experiments. Data from three independent experiments, samples pooled from n = 6 mice total (2 mice per experiment). e, Representative blot showing Opa1 expression in polarized wild-type or P2rx7 −/− P14 cells, in comparison with β-actin (for gel source data, see Supplementary Fig. 1 ). f, Opa1 protein levels in polarized wild-type or P2rx7 −/− P14 cells, normalized to β-actin. 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Data analysis
FlowJo (Treestar Inc., v10), Prism (GraphPad Inc., v5 and v7) and Photoshop (Adobe Inc., v6).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability Data are available from the corresponding author upon reasonable request.
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Population characteristics females.
Recruitment
Samples were randomly selected from available leukapheresis products Flow Cytometry Plots Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology Sample preparation
A description of the sample preparations for flow cytometry is detailed in the Methods section.
Instrument
We used a LSR Fortessa II flow cytometry machine (BD Biosciences; 5 lasers -blue, red, UV, violet, Yellow-Green; 18 fluorescent parameters). For sorting, we used a FACSAria machine (BD Biosciences).
Software
We used the software FACSDiva (BD Biosciences) to collect the data and the software FlowJo v10 (Treestar Inc.) to analyze the data.
Cell population abundance After cell sorting, we obtained between 10e5 and 5x10e5 cells from each target population (which were then used for RNA sequencing or "Seahorse" metabolism assays). Post-sort analysis showed >95% purity of target subpopulations.
Gating strategy
For all experiments, we first selected lymphocytes based on FSCxSSC; then, we selected the singlets based on SSC-H x SSC-W; then we selected viable cells based on SSC x Live-Dead gating. After, we selected CD8+ cells based on CD8 x SSC-A, or CD8 x CD4 gating. To select antigen-specific cells we either used congenic CD45 labeling (as determined in Fig. 1b ) or we used gp33tetramer x CD44 gating, selecting the double-positive cells.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
